Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRowena Brook, Mani Suleiman, Brandon Lui, Ramzi Ajjan, Harshal H. Nandurkar, Suresh Varadarajan, Prahlad W. Ho, Hui Yin Lim
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research
10.4239/wjd.v6.i13.1246 · 2015
Glycaemic control and macrovascular and microvascular outcomes: a systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes
10.1111/dom.15511 · 2024
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
10.1007/s00125-021-05640-y · 2022
Global coagulation assays in hypercoagulable states
10.1007/s11239-021-02621-1 · 2022
Global coagulation assays in patients with diabetes mellitus
10.1002/rth2.12611 · 2021
General cardiovascular risk profile for use in primary care
10.1161/circulationaha.107.699579 · 2008
Diagnosis and classification of diabetes mellitus
2013
Risk factors for thrombosis in dialysis patients: a comprehensive systematic review and meta-analysis
10.1016/j.jvn.2024.05.002 · 2024
The predictive value of thromboelastography (TEG) parameters in vascular complications in patients with type 2 diabetes mellitus
10.1016/j.jdiacomp.2022.108236 · 2022
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis
10.1160/th13-07-0566 · 2014
Elevated von Willebrand factor (VWF) and factor VIII are associated with higher clinical SYNTAX score in patients with stable coronary artery disease [abstract]
2019
Regulation of VWF (von Willebrand factor) in inflammatory thrombosis
10.1161/atvbaha.122.318179 · 2022
Changes of fibrinolysis and factor VIII coagulant, antigen, and ristocetin cofactor in diabetes mellitus and atherosclerosis
10.1016/0049-3848(80)90011-0 · 1980
Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the Framingham offspring study
10.1161/circulationaha.108.792986 · 2008
No additional external references are available.